BD
Brian H Dovey
Director

Brian H Dovey insider trades: REVA Medical (RVA) stock buys and sales

Director, REVA Medical Last trade Nov 11, 2019 253 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
188
Open-market trades
since 2006
37
Companies
last trade 2019

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Brian reports to the SEC

and 31 more companies

Open-market buys and sales

188 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 11, 2019RVA↓ Sell$2
Nov 11, 2019RVA↓ Sell$2
Aug 6, 2019OBLN↑ Buy$1.0M
Aug 23, 2018OBLN↑ Buy$3.0M
Aug 23, 2018BNGO↑ Buy$92K
Aug 3, 2016CLCD↓ Sell$1.3M
Aug 3, 2016CLCD↓ Sell$2K
May 26, 2016EVOK↓ Sell$1.6M
May 26, 2016EVOK↓ Sell$28K
Apr 28, 2016CLCD↓ Sell$1.0M
Apr 28, 2016CLCD↓ Sell$2K
Apr 27, 2016EVOK↓ Sell$26K
Apr 27, 2016EVOK↓ Sell$415
Apr 20, 2016EVOK↓ Sell$222K
Apr 20, 2016EVOK↓ Sell$4K
Apr 11, 2016EVOK↓ Sell$23K
Apr 11, 2016EVOK↓ Sell$392
Apr 8, 2016EVOK↓ Sell$269K
Apr 8, 2016EVOK↓ Sell$5K
Aug 18, 2015EVOK↓ Sell$83K
Aug 18, 2015EVOK↓ Sell$1K
May 4, 2015TBRA↑ Buy$2.9M
Apr 16, 2015EVOK↓ Sell$366K
Apr 16, 2015EVOK↓ Sell$6K
Nov 25, 2014NEOT↑ Buy$980K
Oct 21, 2014ESPR↑ Buy$10.0M
Oct 21, 2014ATRA↑ Buy$2.7M
Oct 21, 2014ATRA↑ Buy$20K
Aug 5, 2014MRNS↑ Buy$3.4M
Jan 16, 2014ALIM↓ Sell$1.9M
Jan 16, 2014ALIM↓ Sell$21K
Aug 27, 2013RGDO↑ Buy$3.0M
Jul 15, 2013OCRX↑ Buy$6.0M
Jul 15, 2013OCRX↑ Buy$2.0M
Jul 15, 2013OCRX↑ Buy$44K
Jul 1, 2013ESPR↑ Buy$3.9M
Jul 1, 2013ESPR↑ Buy$67K
Jun 20, 2013ALIM↓ Sell$53K
Jun 20, 2013ALIM↓ Sell$571
Jun 19, 2013ALIM↓ Sell$298K
Jun 19, 2013ALIM↓ Sell$3K
Jun 17, 2013ALIM↓ Sell$670K
Jun 17, 2013ALIM↓ Sell$7K
Jun 11, 2013ALIM↓ Sell$27K
Jun 11, 2013ALIM↓ Sell$295
Jun 4, 2013CLVS↓ Sell$10.3M
Jun 4, 2013CLVS↓ Sell$179K
May 16, 2013ALIM↓ Sell$204K
May 16, 2013ALIM↓ Sell$2K
Apr 15, 2013CADX↓ Sell$474K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Brian H Dovey's insider trades

Brian H Dovey is a director at REVA Medical (RVA). Since May 15, 2006, Brian has reported 55 open-market purchases worth $126.3M and 133 sales worth $70.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include conversions (50 filings), other transactions (41 filings), grants and awards (23 filings), option exercises (11 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RVA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.